Strides Shasun Receives USFDA Approval For Lbuprofen Tablets


Strides Shasun Limited in its BSE filing on Thursday announced that it has received approval from the USFDA for Ibuprofen Tablets USP, 200 mg (OTC).

According to IRI data, the US market for Ibuprofen Tablets USP, 200 mg (OTC) is approx. $200 million. The approval further strengthens company’s fast-growing global OTC franchise. The product will be marketed by Strides Pharma Inc in the US market under its OTC brand Nuprin.

Ibuprofen is used to relieve pain from various conditions such as headache, dental pain, muscle pain, muscle aches, or arthritis. It is also used to reduce fever and minor aches and pain due to the common cold or flu. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID).  Strides Shasun Limited was trading over 6% as at 11.55 on Thursday, on the BSE.

For Quick Trial – 8962000225 ✔ 
or mail us here: info@ways2capital.com
or visit http://www.ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 ✔ 
Give a Missed Call for Free Trial - 09699997717 ✔
Share on Google Plus

About Suhani Varma

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.

0 comments: